Publisher's Synopsis
Cancer of the prostate has been recognized over the past decade as the most common form of cancer in males. This book summarizes the conditions and concerns relating to existing methods of treating prostate cancer, such as surgery, radiation, chemotherapy, and chemoendocrine therapy. It also covers the results of clinical trials of Zoladex (a biodegradable sustained-release depot formulation of a luteinizing hormone-releasing hormone agonist analogue, goserelin acetate) held in Japan, and includes accounts of the wide experience obtained in Europe and the USA with this drug. New trends and developments in the field of prostate cancer treatment worldwide are also discussed. Aimed primarily at oncologists and urologists, this book will be of great value to all those currently active in the field of prostate cancer.
